# Bavarian Nordic Secures Four-Year UK Health Security Agency MVA-BN Vaccine Contract

> Bavarian Nordic will supply its MVA-BN mpox and smallpox vaccine to the UK Health Security Agency under a four-year contract with scheduled deliveries.

- Published: 2026-11-02T07:18:28+00:00
- Section: Contracts & Customers
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-02/bavarian-nordic-uk-vaccine-contract
- Source: [FinancialContent Business Page](https://www.financialcontent.com/article/gnwcq-2026-11-2-bavarian-nordic-awarded-multi-year-vaccine-contract-by-uk-government)

## Key takeaways

- Bavarian Nordic was awarded a four-year contract by the UK Health Security Agency to supply MVA-BN, its non-replicating mpox and smallpox vaccine.
- The contract includes scheduled deliveries across the term and optional flexibility provisions.
- MVA-BN is the only non-replicating mpox vaccine approved in the U.S., Switzerland, Singapore, Mexico, Canada, the EU/EEA and the United Kingdom.

Bavarian Nordic has been awarded a four-year contract by the UK Government through the UK Health Security Agency to supply MVA-BN, its non-replicating mpox and smallpox vaccine. The [FinancialContent Business Page](https://www.financialcontent.com/article/gnwcq-2026-11-2-bavarian-nordic-awarded-multi-year-vaccine-contract-by-uk-government) reported the award on November 2, 2026. Bavarian Nordic is a Denmark-based vaccine company that supplies governments with mpox and smallpox vaccines and sells a portfolio of travel vaccines.

## Bavarian Nordic's MVA-BN Supply Terms

Under the four-year contract, [Bavarian Nordic](https://akta.pro/company-profiles/0000q1l/bavarian-nordic) will supply MVA-BN through scheduled deliveries across the term. The contract also includes optional flexibility provisions. The award reinforces the longstanding partnership between the company and the UK government and supports the UK's commitment to maintaining vaccine preparedness and response capabilities against public health threats.

Sarah Collins, Director, Commercial, Vaccines & Countermeasures Delivery at UKHSA, said: "It is vital to ensure that the UK has the right vaccines available to protect the public from a range of infectious disease threats." Hitesh Sahni, Senior Vice President, Public Preparedness at Bavarian Nordic, said: "We are pleased to continue supporting the UK government's preparedness efforts through this multi-year agreement."

MVA-BN, or Modified Vaccinia Ankara-Bavarian Nordic, is the only non-replicating mpox vaccine approved in the U.S., Switzerland, Singapore, Mexico (marketed as JYNNEOS), Canada (marketed as IMVAMUNE), the EU/EEA and the United Kingdom (marketed as IMVANEX). It was originally developed as a smallpox vaccine in collaboration with the U.S. government and is indicated for use in the general population from 2 years old in individuals considered at risk for smallpox or mpox infection.

## Bavarian Nordic's Revenue and Funding Records

According to akta.pro [company records](https://akta.pro/company-data), Bavarian Nordic's full-year 2025 revenue exceeded its latest guidance of approximately DKK 6,000 million, with preliminary 2025 revenue of DKK 6,244 million. The company reported Q1 2026 revenue of DKK 1,058 million with EBITDA of DKK 165 million. The same records list total funding of $329.6 million, with the last round dated September 4, 2026.

## Bavarian Nordic's Earlier Mpox and Leadership Moves

On October 27, 2026, Bavarian Nordic said it would donate 75,000 doses of its MVA-BN mpox vaccine to a global emergency stockpile managed by the WHO-hosted International Coordinating Group on Vaccine Provision, Yahoo reported. On September 17, 2026, STAT reported that Bavarian Nordic appointed Tarja Stenvall as CEO, replacing Paul Chaplin, effective October 15, after a failed takeover bid.

## Bavarian Nordic's Scheduled Deliveries Under the Contract

Bavarian Nordic will supply MVA-BN through scheduled deliveries across the four-year term, with optional flexibility provisions included in the contract.

## Companies in this story

- [Bavarian Nordic company profile](https://akta.pro/company-profiles/0000q1l/bavarian-nordic) · website: http://www.bavarian-nordic.com

---
News for Agent · https://newsforagent.com/llms.txt